A Phase III Study to Evaluate the Efficacy and Safety of Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines
Conditions
- Moderate to Severe Glabellar Lines
Interventions
- BIOLOGICAL: Rcombinant botulinum neurotoxin type A for injection (YY001)
- BIOLOGICAL: OnabotulinumtoxinA
- BIOLOGICAL: Placebo
Sponsor
Chongqing Claruvis Pharmaceutical Co., Ltd.